DTIL – Precision BioSciences, Inc.
Precision BioSciences, Inc.DTIL
$5.09Name : Precision BioSciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $122,404,856.00
EPSttm : -8.96
Precision BioSciences, Inc.
$5.09
13.52%$0.795Float Short %
4.57
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
1.68
EPS Last/This Y
-7.62
EPS This/Next Y
2.38
Price
5.85
Target Price
32.5
Analyst Recom
1
Performance Q
18.79
Relative Volume
1.33
Beta
1.14
Ticker: DTIL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | DTIL | 7.16 | N/A | N/A | 0 |
| 2025-10-21 | DTIL | 6.99 | N/A | N/A | 0 |
| 2025-10-22 | DTIL | 6.84 | N/A | N/A | 0 |
| 2025-10-23 | DTIL | 6.87 | N/A | N/A | 0 |
| 2025-10-24 | DTIL | 6.67 | N/A | N/A | 0 |
| 2025-10-27 | DTIL | 7.05 | N/A | N/A | 0 |
| 2025-10-28 | DTIL | 8.36 | N/A | N/A | 0 |
| 2025-10-29 | DTIL | 8.41 | N/A | N/A | 0 |
| 2025-10-30 | DTIL | 8.61 | N/A | N/A | 0 |
| 2025-10-31 | DTIL | 8.04 | N/A | N/A | 0 |
| 2025-11-03 | DTIL | 7.35 | N/A | N/A | 0 |
| 2025-11-04 | DTIL | 6.65 | N/A | N/A | 0 |
| 2025-11-05 | DTIL | 6.62 | N/A | N/A | 0 |
| 2025-11-06 | DTIL | 6.38 | 0.00 | 0.00 | 0 |
| 2025-11-07 | DTIL | 6.13 | 0.00 | 0.00 | 145 |
| 2025-11-10 | DTIL | 6.02 | 0.00 | 0.00 | 145 |
| 2025-11-11 | DTIL | 5.94 | 0.00 | 999.99 | 365 |
| 2025-11-12 | DTIL | 5.99 | 0.00 | 999.99 | 365 |
| 2025-11-13 | DTIL | 5.85 | 0.00 | 999.99 | 365 |
| 2025-11-14 | DTIL | 5.86 | 0.00 | 999.99 | 365 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | DTIL | 7.16 | 1.8 | - | -7.90 |
| 2025-10-21 | DTIL | 6.99 | 1.8 | - | -7.90 |
| 2025-10-22 | DTIL | 6.93 | 1.8 | - | -7.90 |
| 2025-10-23 | DTIL | 6.91 | 1.8 | - | -7.90 |
| 2025-10-24 | DTIL | 6.68 | 1.8 | - | -7.90 |
| 2025-10-27 | DTIL | 7.11 | 1.8 | - | -7.90 |
| 2025-10-28 | DTIL | 8.29 | 1.8 | - | -7.90 |
| 2025-10-29 | DTIL | 8.46 | 1.8 | - | -7.90 |
| 2025-10-30 | DTIL | 8.61 | 1.8 | - | -7.90 |
| 2025-10-31 | DTIL | 8.16 | 1.8 | - | -7.90 |
| 2025-11-03 | DTIL | 7.38 | 1.8 | - | -7.90 |
| 2025-11-04 | DTIL | 6.68 | 1.8 | - | -7.90 |
| 2025-11-05 | DTIL | 6.65 | 1.8 | - | -7.90 |
| 2025-11-06 | DTIL | 6.41 | 1.8 | - | -7.90 |
| 2025-11-07 | DTIL | 6.14 | 57.2 | - | -7.90 |
| 2025-11-10 | DTIL | 6.07 | 57.2 | - | -7.90 |
| 2025-11-11 | DTIL | 6.00 | 57.2 | - | -7.90 |
| 2025-11-12 | DTIL | 5.96 | 57.2 | - | -7.90 |
| 2025-11-13 | DTIL | 5.82 | 57.2 | - | -7.90 |
| 2025-11-14 | DTIL | 5.85 | 59.3 | - | -6.57 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | DTIL | -0.17 | 6.15 | 12.00 |
| 2025-10-21 | DTIL | -0.17 | 6.15 | 12.00 |
| 2025-10-22 | DTIL | -0.17 | 6.15 | 12.00 |
| 2025-10-23 | DTIL | -0.17 | 6.15 | 12.00 |
| 2025-10-24 | DTIL | -0.17 | 6.15 | 12.00 |
| 2025-10-27 | DTIL | -0.17 | 5.72 | 4.90 |
| 2025-10-28 | DTIL | -0.17 | 5.72 | 4.90 |
| 2025-10-29 | DTIL | -0.17 | 5.72 | 4.90 |
| 2025-10-30 | DTIL | -0.17 | 5.72 | 4.90 |
| 2025-10-31 | DTIL | -0.17 | 5.72 | 4.90 |
| 2025-11-03 | DTIL | -0.17 | 5.91 | 4.90 |
| 2025-11-04 | DTIL | -0.40 | 5.91 | 4.90 |
| 2025-11-05 | DTIL | -0.40 | 5.91 | 4.90 |
| 2025-11-06 | DTIL | -0.36 | 5.91 | 4.90 |
| 2025-11-07 | DTIL | -0.36 | 5.91 | 4.36 |
| 2025-11-10 | DTIL | -0.36 | 5.60 | 4.36 |
| 2025-11-11 | DTIL | -0.36 | 5.60 | 4.36 |
| 2025-11-12 | DTIL | -0.36 | 5.60 | 4.57 |
| 2025-11-13 | DTIL | -0.36 | 5.60 | 4.57 |
| 2025-11-14 | DTIL | -0.36 | 5.60 | 4.57 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.84
Avg. EPS Est. Current Quarter
-0.87
Avg. EPS Est. Next Quarter
-0.16
Insider Transactions
-0.36
Institutional Transactions
5.6
Beta
1.14
Average Sales Estimate Current Quarter
8
Average Sales Estimate Next Quarter
6
Fair Value
Quality Score
10
Growth Score
32
Sentiment Score
54
Actual DrawDown %
98.8
Max Drawdown 5-Year %
-99.2
Target Price
32.5
P/E
Forward P/E
PEG
P/S
111.35
P/B
4.27
P/Free Cash Flow
EPS
-8.4
Average EPS Est. Cur. Y
-6.57
EPS Next Y. (Est.)
-4.19
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-11977.36
Relative Volume
1.33
Return on Equity vs Sector %
-529.5
Return on Equity vs Industry %
-514.7
EPS 1 7Days Diff
1.3
EPS 1 30Days Diff
1.33
EBIT Estimation
Precision BioSciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 67
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
stock quote shares DTIL – Precision BioSciences, Inc. Stock Price stock today
news today DTIL – Precision BioSciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences, Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences, Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading